Intag Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 15.39%
- Profit Growth -7.86%
- Ebitda 56.71%
- Net Worth 29.21%
- Total Assets 9.23%
About Intag Remedies
Intag Remedies Private Limited (IRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 March 2008 and has a history of 16 years and ten months. Its registered office is in Guwahati, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sarda Damani, Narayan Gattani, Madhu Periwal, and Two other members serve as directors at the Company.
Company Details
-
Location
Guwahati, Assam, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397AS2008PTC008633
-
Company No.
008633
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Mar 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
What products or services does Intag Remedies Private Limited offer?
Intag Remedies Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Brain & Nervous System Drugs, Immunomodulator Drugs, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Injectable Products, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Intag Remedies?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarda Damani
|
Director | 19-Mar-2008 | Current |
|
Narayan Gattani
|
Director | 19-Mar-2008 | Current |
|
Madhu Periwal
|
Director | 19-Mar-2008 | Current |
|
Bijay Kumar
|
Director | 19-Mar-2008 | Current |
|
Deepak Damani
|
Director | 16-Jul-2008 | Current |
Financial Performance of Intag Remedies.
Intag Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.39% increase. The company also saw a slight decrease in profitability, with a 7.86% decrease in profit. The company's net worth Soared by an impressive increase of 29.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intag Remedies?
In 2023, Intag Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Precaution Healthcare Private LimitedNarayan Gattani and Madhu Periwal are mutual person
-
Tirupati Slg Plastic Private Limited
Madhu Periwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Intag Remedies?
Intag Remedies has a workforce of 54 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intag Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intag Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.